0001343304-15-000003.txt : 20151125 0001343304-15-000003.hdr.sgml : 20151125 20151125120948 ACCESSION NUMBER: 0001343304-15-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20151125 DATE AS OF CHANGE: 20151125 EFFECTIVENESS DATE: 20151125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AVEDRO INC CENTRAL INDEX KEY: 0001343304 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-251933 FILM NUMBER: 151255132 BUSINESS ADDRESS: STREET 1: 230 THIRD AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781 768 3400 MAIL ADDRESS: STREET 1: 230 THIRD AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 D 1 primary_doc.xml X0707 D LIVE 0001343304 AVEDRO INC 230 THIRD AVENUE WALTHAM MA MASSACHUSETTS 02451 781-768-3400 DELAWARE None None Corporation true David F. Muller c/o Avedro, Inc. 230 Third Avenue Waltham MA MASSACHUSETTS 02451 Executive Officer Director Philip J. Ferneau c/o Borealis Ventures 10 Allen Street Hanover NH NEW HAMPSHIRE 03755 Director Anthony J. Natale c/o Prism VentureWorks 1212 Abbot Kinney Boulevard, Unit B Venice CA CALIFORNIA 90291 Director Joseph Mandato c/o De Novo Ventures 14612 Big Basin Way, Suite B Saratoga CA CALIFORNIA 95070 Director M. Carl Johnson, III c/o Avedro, Inc. 230 Third Avenue Waltham MA MASSACHUSETTS 02451 Director Brian J. Roberts c/o Avedro, Inc. 230 Third Avenue Waltham MA MASSACHUSETTS 02451 Executive Officer Jeff Dykan c/o SCP Vitalife Partners 1200 Liberty Ridge Drive, Suite 300 Wayne PA PENNSYLVANIA 19087 Director Robert Palmisano c/o Avedro, Inc. 230 Third Avenue Waltham MA MASSACHUSETTS 02451 Director Steve Blinn c/o Avedro, Inc. 230 Third Avenue Waltham MA MASSACHUSETTS 02451 Executive Officer Other Health Care Decline to Disclose 06b false 2015-11-13 false true false 0 32000000 16533010 15466990 Total Offering Amount includes a rights offering of $200,014. Amount Sold includes P&I under outstanding promissory notes. Remainder to be sold contingent on the occurrence of certain events. false 23 0 0 0 false AVEDRO INC /s/ Brian Roberts Brian Roberts CFO 2015-11-25